Canada markets open in 9 hours 23 minutes

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
24.42+0.88 (+3.74%)
At close: 04:00PM EDT
23.77 -0.65 (-2.66%)
After hours: 06:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 649.87M
Enterprise Value 435.71M
Trailing P/E 478.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.54
Price/Book (mrq)1.61
Enterprise Value/Revenue 1.74
Enterprise Value/EBITDA -24.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.93
52-Week Change 36.78%
S&P500 52-Week Change 326.43%
52 Week High 326.70
52 Week Low 39.26
50-Day Moving Average 320.86
200-Day Moving Average 319.44

Share Statistics

Avg Vol (3 month) 3255.8k
Avg Vol (10 day) 3341.87k
Shares Outstanding 527.61M
Implied Shares Outstanding 627.61M
Float 826.8M
% Held by Insiders 13.03%
% Held by Institutions 188.93%
Shares Short (Apr 15, 2024) 41.46M
Short Ratio (Apr 15, 2024) 47.73
Short % of Float (Apr 15, 2024) 45.45%
Short % of Shares Outstanding (Apr 15, 2024) 45.29%
Shares Short (prior month Mar 15, 2024) 41.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -12.28%
Operating Margin (ttm)-7.50%

Management Effectiveness

Return on Assets (ttm)-5.92%
Return on Equity (ttm)-7.82%

Income Statement

Revenue (ttm)250.72M
Revenue Per Share (ttm)9.28
Quarterly Revenue Growth (yoy)73.60%
Gross Profit (ttm)N/A
EBITDA -29.15M
Net Income Avi to Common (ttm)-30.8M
Diluted EPS (ttm)-1.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)239.21M
Total Cash Per Share (mrq)8.66
Total Debt (mrq)25.07M
Total Debt/Equity (mrq)6.23%
Current Ratio (mrq)9.26
Book Value Per Share (mrq)14.59

Cash Flow Statement

Operating Cash Flow (ttm)12.98M
Levered Free Cash Flow (ttm)2.38M